Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 323.50
-6.80 (-2.06%)
Oct 23, 2026, 3:28 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 526.75 billion as of October 22, 2026. It is the 3,281st most valuable company in the world and the 191st biggest in India. Its market cap has increased by 7.82% in one year.
Market Cap
526.75B
Enterprise Value
668.16B
Revenue
173.21B
Global Rank
Country Rank
#191 India
PE Ratio
96.08
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 526.75B, an increase of 1,059.92%. That is a compound annual growth rate of 11.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 526.75B | 0.21% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 454.27B |
| OneSource Specialty Pharma | 156.74B |
| Concord Biotech | 132.08B |
| Blue Jet Healthcare | 94.97B |
| Supriya Lifescience | 68.91B |
| Zota Health Care | 46.10B |
| Dishman Carbogen Amcis | 22.30B |
| Panacea Biotec | 21.03B |